NCT05050682View on ClinicalTrials.gov

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions
Healthy
Interventions
DRUG

PF-07304814

PF-07304814 is an anti-viral, formulated for intravenous delivery

Trial Locations (1)

53704

Fortrea Clinical Research Unit - Madison, Madison

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05050682 - Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants | Biotech Hunter | Biotech Hunter